Researchers from the University of Texas Health Science Center at Houston (UTHealth) and Rice University have created and evaluated a peptide-based immunotherapy known.
Oral surgeons at the UTHealth School of Dentistry at Houston are participating in a multicenter, phase one/phase two clinical trials of a drug-releasing patch.